JBT MAREL CORP (JBTM) Stock Fundamental Analysis

NYSE:JBTM • US4778391049

152.63 USD
-1.76 (-1.14%)
Last: Mar 3, 2026, 03:04 PM
Fundamental Rating

4

Taking everything into account, JBTM scores 4 out of 10 in our fundamental rating. JBTM was compared to 130 industry peers in the Machinery industry. JBTM may be in some trouble as it scores bad on both profitability and health. JBTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • JBTM had positive earnings in the past year.
  • JBTM had a positive operating cash flow in the past year.
  • JBTM had positive earnings in 4 of the past 5 years.
  • In the past 5 years JBTM always reported a positive cash flow from operatings.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.62%, JBTM is doing worse than 71.54% of the companies in the same industry.
  • The Return On Equity of JBTM (-1.13%) is worse than 68.46% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.97%, JBTM is doing worse than 65.38% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for JBTM is significantly below the industry average of 10.21%.
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROIC 2.97%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.56%
ROIC(5y)5.43%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • Looking at the Operating Margin, with a value of 5.80%, JBTM is doing worse than 60.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of JBTM has declined.
  • JBTM has a Gross Margin of 35.15%. This is in the better half of the industry: JBTM outperforms 63.85% of its industry peers.
  • In the last couple of years the Gross Margin of JBTM has grown nicely.
Industry RankSector Rank
OM 5.8%
PM (TTM) N/A
GM 35.15%
OM growth 3Y-13.13%
OM growth 5Y-10.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBTM is destroying value.
  • Compared to 1 year ago, JBTM has more shares outstanding
  • Compared to 5 years ago, JBTM has more shares outstanding
  • JBTM has a better debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • JBTM has an Altman-Z score of 2.09. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of JBTM (2.09) is comparable to the rest of the industry.
  • JBTM has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as JBTM would need 7.90 years to pay back of all of its debts.
  • JBTM has a Debt to FCF ratio (7.90) which is comparable to the rest of the industry.
  • JBTM has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • JBTM has a better Debt to Equity ratio (0.33) than 60.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 7.9
Altman-Z 2.09
ROIC/WACC0.33
WACC9.03%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • JBTM has a Current Ratio of 0.98. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of JBTM (0.98) is worse than 87.69% of its industry peers.
  • A Quick Ratio of 0.58 indicates that JBTM may have some problems paying its short term obligations.
  • JBTM has a worse Quick ratio (0.58) than 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.58
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.10% over the past year.
  • The Earnings Per Share has been growing by 10.06% on average over the past years. This is quite good.
  • Looking at the last year, JBTM shows a very strong growth in Revenue. The Revenue has grown by 121.34%.
  • The Revenue has been growing by 17.06% on average over the past years. This is quite good.
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%

3.2 Future

  • Based on estimates for the next years, JBTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.54% on average per year.
  • The Revenue is expected to grow by 5.56% on average over the next years.
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue Next Year6.73%
Revenue Next 2Y5.73%
Revenue Next 3Y5.56%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.92, JBTM is valued on the expensive side.
  • Based on the Price/Earnings ratio, JBTM is valued a bit cheaper than 62.31% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.13. JBTM is around the same levels.
  • JBTM is valuated rather expensively with a Price/Forward Earnings ratio of 18.22.
  • JBTM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. JBTM is cheaper than 75.38% of the companies in the same industry.
  • JBTM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.92
Fwd PE 18.22
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • JBTM's Enterprise Value to EBITDA is on the same level as the industry average.
  • JBTM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 33.31
EV/EBITDA 20.02
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • JBTM's earnings are expected to grow with 18.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)2.38
EPS Next 2Y22.03%
EPS Next 3Y18.54%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.26%, JBTM is not a good candidate for dividend investing.
  • JBTM's Dividend Yield is comparable with the industry average which is at 1.13.
  • Compared to an average S&P500 Dividend Yield of 1.82, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.26%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 4.31%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-41.39%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

JBT MAREL CORP

NYSE:JBTM (3/3/2026, 3:04:53 PM)

152.63

-1.76 (-1.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners99.18%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change3.71%
Market Cap7.93B
Revenue(TTM)3.80B
Net Income(TTM)-50.50M
Analysts83.33
Price Target159.94 (4.79%)
Short Float %4.99%
Short Ratio5.06
Dividend
Industry RankSector Rank
Dividend Yield 0.26%
Yearly Dividend0.5
Dividend Growth(5Y)4.31%
DP-41.39%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.53%
Min EPS beat(2)0.65%
Max EPS beat(2)26.4%
EPS beat(4)4
Avg EPS beat(4)13.8%
Min EPS beat(4)0.65%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.07%
EPS beat(12)9
Avg EPS beat(12)5.79%
EPS beat(16)12
Avg EPS beat(16)7.67%
Revenue beat(2)1
Avg Revenue beat(2)2.41%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.3%
Revenue beat(12)4
Avg Revenue beat(12)-4.47%
Revenue beat(16)5
Avg Revenue beat(16)-3.58%
PT rev (1m)0%
PT rev (3m)3.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.21%
EPS NY rev (1m)0%
EPS NY rev (3m)5.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.36%
Valuation
Industry RankSector Rank
PE 23.92
Fwd PE 18.22
P/S 2.09
P/FCF 33.31
P/OCF 23.21
P/B 1.78
P/tB N/A
EV/EBITDA 20.02
EPS(TTM)6.38
EY4.18%
EPS(NY)8.38
Fwd EY5.49%
FCF(TTM)4.58
FCFY3%
OCF(TTM)6.57
OCFY4.31%
SpS73.08
BVpS85.89
TBVpS-20.91
PEG (NY)0.76
PEG (5Y)2.38
Graham Number111.04
Profitability
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROCE 3.35%
ROIC 2.97%
ROICexc 3.05%
ROICexgc 22.87%
OM 5.8%
PM (TTM) N/A
GM 35.15%
FCFM 6.27%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.56%
ROIC(5y)5.43%
ROICexc(3y)6.15%
ROICexc(5y)6.51%
ROICexgc(3y)26.08%
ROICexgc(5y)24.27%
ROCE(3y)5.13%
ROCE(5y)6.12%
ROICexgc growth 3Y6.06%
ROICexgc growth 5Y-7.67%
ROICexc growth 3Y-21.96%
ROICexc growth 5Y-23.95%
OM growth 3Y-13.13%
OM growth 5Y-10.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 7.9
Debt/EBITDA 3.02
Cap/Depr 38.92%
Cap/Sales 2.73%
Interest Coverage 250
Cash Conversion 70.25%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.58
Altman-Z 2.09
F-Score3
WACC9.03%
ROIC/WACC0.33
Cap/Depr(3y)47.22%
Cap/Depr(5y)64.88%
Cap/Sales(3y)2.75%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%
Revenue Next Year6.73%
Revenue Next 2Y5.73%
Revenue Next 3Y5.56%
Revenue Next 5YN/A
EBIT growth 1Y83.81%
EBIT growth 3Y16.11%
EBIT growth 5Y4.61%
EBIT Next Year73.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3Y60.4%
FCF growth 5Y1.81%
OCF growth 1Y46.28%
OCF growth 3Y33.91%
OCF growth 5Y6.28%

JBT MAREL CORP / JBTM FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 4 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 4 / 10 to JBT MAREL CORP (JBTM). This can be considered as Fairly Valued.


How profitable is JBT MAREL CORP (JBTM) stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the financial health of JBT MAREL CORP (JBTM) stock?

The financial health rating of JBT MAREL CORP (JBTM) is 3 / 10.


How sustainable is the dividend of JBT MAREL CORP (JBTM) stock?

The dividend rating of JBT MAREL CORP (JBTM) is 3 / 10 and the dividend payout ratio is -41.39%.